Cargando…

Physical Frailty and Use of Guideline‐Recommended Drugs in Patients With Heart Failure and Reduced Ejection Fraction

BACKGROUND: Guideline‐recommended therapies that improve prognosis remain underused in clinical practice. Physical frailty may lead to underprescription of life‐saving therapy. We aimed to investigate the association between physical frailty and the use of evidence‐based pharmacological therapy for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kondo, Toru, Adachi, Takuji, Kobayashi, Kiyonori, Okumura, Takahiro, Izawa, Hideo, Murohara, Toyoaki, McMurray, John J. V., Yamada, Sumio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356033/ https://www.ncbi.nlm.nih.gov/pubmed/37301739 http://dx.doi.org/10.1161/JAHA.122.026844

Ejemplares similares

Prognostic score based on physical frailty in patients with heart failure: a multicenter prospective cohort study (FLAGSHIP)
por: Yamada, Sumio, et al.
Publicado: (2021)

A multicenter prospective cohort study to develop frailty-based prognostic criteria in heart failure patients (FLAGSHIP): rationale and design
por: Yamada, Sumio, et al.
Publicado: (2018)

Differences in Prognosis and Cardiac Function According to Required Percutaneous Mechanical Circulatory Support and Histological Findings in Patients With Fulminant Myocarditis: Insights From the CHANGE PUMP 2 Study
por: Kondo, Toru, et al.
Publicado: (2022)

Frailty interferes with the guideline‐directed medical therapy in heart failure patients with reduced ejection fraction
por: Hamada, Tomoyuki, et al.
Publicado: (2022)

Adolescent Kawasaki disease shock syndrome with inflammatory cell infiltration into the myocardium: a case report
por: Sugiura, Yuki, et al.
Publicado: (2020)

Relationship between spleen size and exercise tolerance in advanced heart failure patients with a left ventricular assist device
por: Hiraiwa, Hiroaki, et al.
Publicado: (2022)

Impact of weight loss in patients with heart failure with preserved ejection fraction: results from the FLAGSHIP study
por: Kamisaka, Kenta, et al.
Publicado: (2021)

Drug therapy for heart failure with reduced ejection fraction: what is the ‘right’ dose?
por: Kondo, Toru, et al.
Publicado: (2022)

Pulmonary Hypertension: Diagnosis, Management, and Treatment
por: Kondo, Takahisa, et al.
Publicado: (2019)

Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction
por: Hamada, Tomoyuki, et al.
Publicado: (2022)

Neuromuscular electrical stimulation is feasible in patients with acute heart failure
por: Kondo, Toru, et al.
Publicado: (2019)

Myocardial Vasculitis Associated With the Immune Checkpoint Inhibitor Pembrolizumab
por: Oishi, Hideo, et al.
Publicado: (2020)

Prognosis in Patients With Cardiogenic Shock Who Received Temporary Mechanical Circulatory Support
por: Kondo, Toru, et al.
Publicado: (2022)

A case of heart failure complicated with double ventricular response triggered by beta blocker
por: Kazama, Shingo, et al.
Publicado: (2020)

Prognostic impact of nutrition measures in patients with heart failure varies with coexisting physical frailty
por: Iida, Yuki, et al.
Publicado: (2023)

Palliative and end-of-life care for heart failure patients in an aging society
por: Okumura, Takahiro, et al.
Publicado: (2018)

The cardiosplenic axis: the prognostic role of the spleen in heart failure
por: Hiraiwa, Hiroaki, et al.
Publicado: (2022)

Amino acid profiling to predict prognosis in patients with heart failure: an expert review
por: Hiraiwa, Hiroaki, et al.
Publicado: (2022)

Prognostic impact of Clinical Frailty Scale in patients with heart failure with preserved ejection fraction
por: Sunaga, Akihiro, et al.
Publicado: (2021)

Genetic Deficiency of Adipose Triglyceride Lipase Is Associated With a Novel Type of Podocytopathy
por: Nagasawa, Yasuyuki, et al.
Publicado: (2021)

A clinical score for predicting left ventricular reverse remodelling in patients with dilated cardiomyopathy
por: Kimura, Yuki, et al.
Publicado: (2021)

A Case of Systemic Capillary Leak Syndrome With Severe Cardiac Dysfunction After mRNA Vaccination for COVID-19
por: Araki, Takashi, et al.
Publicado: (2022)

Predictors and Outcomes of Heart Failure With Preserved Ejection Fraction in Patients With a Left Ventricular Ejection Fraction Above or Below 60%
por: Nakagawa, Akito, et al.
Publicado: (2022)

Prognostic effects of cardiac rehabilitation in heart failure patients classified according to physical frailty: A propensity score–matched analysis of a nationwide prospective cohort study
por: Adachi, Takuji, et al.
Publicado: (2023)

Multidisciplinary Approaches for Transthyretin Amyloidosis
por: Koike, Haruki, et al.
Publicado: (2021)

Implications of uremic cardiomyopathy for the practicing clinician: an educational review
por: Hiraiwa, Hiroaki, et al.
Publicado: (2023)

Insights into foundational therapies for heart failure with reduced ejection fraction
por: McMurray, John J. V., et al.
Publicado: (2022)

Biopsy-Proven Fulminant Myocarditis Requiring Mechanical Circulatory Support Following COVID-19 mRNA Vaccination
por: Kazama, Shingo, et al.
Publicado: (2022)

Serum autotaxin as a novel prognostic marker in patients with non‐ischaemic dilated cardiomyopathy
por: Araki, Takashi, et al.
Publicado: (2022)

Prognostic value of resting cardiac power index depends on mean arterial pressure in dilated cardiomyopathy
por: Morimoto, Ryota, et al.
Publicado: (2021)

Left ventricular end-diastolic dimension and septal e′ are predictors of cardiac index at rest, while tricuspid annular plane systolic excursion is a predictor of peak oxygen uptake in patients with pulmonary hypertension
por: Nakano, Yoshihisa, et al.
Publicado: (2017)

Geriatric nutritional risk index as readmission predictor in older adults with heart failure irrespective of ejection fraction
por: Sato, Yoshihiro, et al.
Publicado: (2023)

A Resuscitated Adult With Left Main Coronary Artery Ostial Atresia and Graves’ Disease: 10-Year Follow-up
por: Kobayashi, Masakazu, et al.
Publicado: (2021)

Composite Biomarkers for Assessing Frailty Status in Stable Older Adults With Cardiovascular Disease
por: Hirashiki, Akihiro, et al.
Publicado: (2022)

Cardiopulmonary Exercise Testing as a Tool for Diagnosing Pulmonary Hypertension in Patients with Dilated Cardiomyopathy
por: Hirashiki, Akihiro, et al.
Publicado: (2016)

Evaluation of Adherence to Guideline for Heart Failure with Reduced Ejection Fraction in Heart Failure with Preserved Ejection Fraction and with or without Atrial Fibrillation
por: Ahn, Min-Soo, et al.
Publicado: (2021)

High-output Heart Failure Caused by a Tumor-related Arteriovenous Fistula: A Case Report and Literature Review
por: Tobe, Akihiro, et al.
Publicado: (2021)

Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction
por: Dewan, Pooja, et al.
Publicado: (2019)

Clinical impact of heart rate change in patients with acute heart failure in the early phase
por: Kazama, Shingo, et al.
Publicado: (2021)

Usefulness of scoring right ventricular function for assessment of prognostic factors in patients with chronic thromboembolic pulmonary hypertension
por: Kamimura, Yoshihiro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3m6svg6g8n2sf2egv0nig9nbrj